Terns Pharmaceuticals, Inc. (TERN)
37.95
+0.20
(+0.53%)
USD |
NASDAQ |
Feb 13, 14:13
Terns Pharmaceuticals Cash from Investing (Quarterly) : 24.50M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 14.64M |
| Ligand Pharmaceuticals, Inc. | -353.44M |
| ADMA Biologics, Inc. | -14.37M |
| Cidara Therapeutics, Inc. | -176.47M |
| Cogent Biosciences, Inc. | -155.05M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -19.77M |
| Free Cash Flow | -77.99M |
| Free Cash Flow Per Share (Quarterly) | -0.2156 |
| Free Cash Flow to Equity (Quarterly) | -19.67M |
| Free Cash Flow to Firm (Quarterly) | -19.77M |
| Free Cash Flow Yield | -2.25% |